$134.08
Today
as of Jul 22, 16:45 ET
Last 30 days
Recent Press Releases & News
How Will AbbVie's $10.9 Billion Acquisition of Apogee Impact Its Dividend?
What This Apogee Insider Move Might Mean After a 247% Stock Run
Apogee Therapeutics (APGE) Jumps Into Focus, Is The Stock Fully Valued?
Overview
52-week range
$34
$95
100% of range
Avg surprise (last 3)
+5.3%
Avg reaction (last 2)
+4.0%
100% positive
Latest IV / EM
2%
EM ±0.4% · $135 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Mon May 11, 2026 | Mar/2026 | $-1.06 | $-1.12 | +5.4% | -11.6% | +1.9% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-1.11 | — | — | — | — | financials |
| Mon Aug 11, 2025 | Jun/2025 | $-1.13 | $-1.03 | -9.7% | — | — | earnings |
| Mon May 12, 2025 | Mar/2025 | $-0.95 | $-1.19 | +20.2% | — | +6.1% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.86 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.60 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.64 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.51 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-3.78 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Mon Aug 10, 2026 | Jun/2026 | OTHER | -$1.10 | -$1.13 | +2.6% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-83M | — | $-71M | $-73M | $-63M | — | $-59M | $-44M |
| Net income | $-74M | — | $-65M | $-66M | $-55M | — | $-49M | $-34M |
| EPS (diluted) | $-1.06 | — | $-1.11 | $-1.13 | $-0.95 | — | $-0.86 | $-0.60 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $452M | — | $108M | $124M | $107M | — | $119M | $307M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $1.07B | $741M | $540M | $516M | $522M | $530M | $534M | $682M |
| Total assets | $1.29B | $937M | $626M | $658M | $714M | $754M | $776M | $801M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $38M | $33M | $40M | $38M | $41M | $37M | $42M | $27M |
| Total equity | — | — | — | — | — | — | — | — |